Burden and Changing Trends of Non-Alcoholic Fatty Liver Disease in China From 1990 to 2021

Jun TANG; Nan ZHENG; Yuxin YAN; Nan ZHANG; Xiaomei REN

doi:10.3881/j.issn.1000-503X.16339

PDF(1456 KB)

Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (4) : 575-581. DOI: 10.3881/j.issn.1000-503X.16339

Original Articles

Burden and Changing Trends of Non-Alcoholic Fatty Liver Disease in China From 1990 to 2021

Jun TANG ¹ ,
Nan ZHENG ¹ ,
Yuxin YAN ¹ ,
Nan ZHANG ¹ ,
Xiaomei REN ²

Author information +

History +

Abstract

Objective To analyze the changing trends of the burden of non-alcoholic fatty liver disease(NAFLD)in China from 1990 to 2021 and provide a basis for formulating prevention and treatment strategies.Methods The standardized incidence rate,prevalence,mortality,and disability-adjusted life year(DALY)rate of NAFLD in China from 1990 to 2021 were extracted from the Global Burden of Disease Study 2021.The average annual percentage change of rate data was calculated by Joinpoint 4.2 and the age,period,and birth cohort effects of the prevalence and DALY rate were analyzed by the age-period-cohort model.Results Compared to 1990,the incidence rate and prevalence of NAFLD have been on the rise,while the mortality and DALY rate have been declining.The age effect curves of prevalence and DALY rate showed an upward trend followed by a downward trend for both males and females.With the period from 1992 to 1996 as the reference group,the period effect curve of prevalence showed a downward trend followed by an upward trend,being the lowest in the period from 2002 to 2006(RR=0.93).The period effect curve of DALY rate showed a downward trend from 1992 to 2011 and then tended to flatten out.With the period from 1972 to 1981 as the reference group,the birth cohort effect curve of prevalence showed a steady upward trend in the general population and both male and female populations.The birth cohort effect curve of DALY rate showed an overall upward trend followed by a downward trend,with the peak occurring in the birth cohort group between 1922 and 1931.The DALY rate of NAFLD caused by smoking and high fasting blood glucose has shown a downward trend since 2014,and fasting blood glucose gradually became the dominant factor as age increased.Conclusions From 1990 to 2021,NAFLD in China has shown a rising prevalence but a significantly declining DALY rate.This suggests that current prevention and control strategies are effective,and further efforts should be made to raise residents’ health awareness in controlling the occurrence and development of NAFLD.

Key words

non-alcoholic fatty liver disease / disease burden / age-period-cohort model

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Jun TANG , Nan ZHENG , Yuxin YAN , et al . Burden and Changing Trends of Non-Alcoholic Fatty Liver Disease in China From 1990 to 2021[J]. Acta Academiae Medicinae Sinicae. 2025, 47(4): 575-581 https://doi.org/10.3881/j.issn.1000-503X.16339

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	杨阳, 李峻, 孔翠丽, 等. 环境污染物致非酒精性脂肪肝研究进展[J]. 生态毒理学报, 2024, 19(3):158-168.DOI:10.7524/AJE.1673-5897.20231212001. Cited in this article [2]

[2]	朱豆豆, 朱升龙, 崔思远, 等. 胆固醇酯对非酒精性脂肪肝药物治疗的影响[J]. 食品与生物技术学报, 2023, 42(7):11-17.DOI:10.3969/j.issn.1673-1689.2023.07.002. Cited in this article [1]

[3]	Iruzubieta P, Bataller R, Arias-Loste MT, et al. Research priorities for precision medicine in NAFLD[J]. Clin Liver Dis, 2023, 27(2):535-551.DOI:10.1016/j.cld.2023.01.016. Cited in this article [1]

[4]	Yang L, Wang H, Xue L. What about the health workforce distribution in rural China? An assessment based on eight-year data[J]. Rural Remote Health, 2019, 19(3):4978.DOI:10.22605/RRH4978. Cited in this article [1]

[5]	Wang F, Fan J, Zhang Z, et al. The global burden of liver disease:the major impact of China[J]. Hepatology, 2014, 60(6):2099-2108.DOI:10.1002/hep.27406. Cited in this article [1]

[6]	Ding C, Fu X, Zhou Y, et al. Disease burden of liver cancer in China from 1997 to 2016:an observational study based on the Global Burden of Diseases[J]. BMJ Open, 2019, 9(4):e025613.DOI:10.1136/bmjopen-2018-025613. Cited in this article [1]

[7]	Wei S, Wang L, Evans PC, et al. NAFLD and NASH: etiology, targets and emerging therapies[J]. Drug Discov Today, 2024, 29(3):103910.DOI:10.1016/j.drudis.2024.103910. Cited in this article [1]

[8]

GBD 2021 Rheumatoid Arthritis Collaborators.Global,regional,and national burden of rheumatoid arthritis,1990-2020,and projections to 2050:a systematic analysis of the Global Burden of Disease Study 2021[J]. Lancet Rheumatol, 2023, 5(10): e594-e610.DOI:10.1016/S2665-9913(23)00211-4.

Cited in this article [1]

[9]	Harrison JE, Weber S, Jakob R, et al. ICD-11:an international classification of diseases for the twenty-first century[J]. BMC Med Inform Decis Mak, 2021, 21(Suppl 6):206.DOI:10.1186/s12911-021-01534-6. Cited in this article [1]

[10]	Chernyavskiy P, Little MP, Rosenberg PS. Correlated poisson models for age-period-cohort analysis[J]. Stat Med, 2018, 37(3):405-424.DOI:10.1002/sim.7519. Cited in this article [1]

[11]	Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018:a systematic review and meta-analysis[J]. Hepatology, 2019, 70(4):1119-1133.DOI:10.1002/hep.30702. Cited in this article [1]

[12]	Wang D, Xu Y, Zhu Z, et al. Changes in the global,regional,and national burdens of NAFLD from 1990 to 2019:a systematic analysis of the global burden of disease study 2019[J]. Front Nutr, 2022,9:1047129.DOI:10.3389/fnut.2022.1047129. Cited in this article [2]

[13]	Li J, Zou B, Yeo YH, et al. Prevalence,incidence, and outcome of non-alcoholic fatty liver disease in Asia,1999-2019:a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2019, 4(5):389-398.DOI:10.1016/S2468-1253(19)30039-1. Cited in this article [1]

[14]	石卓跃, 杨颖, 韩金慧, 等. 健康体检人群非酒精性脂肪肝患病现状及共病相关性分析[J]. 中国煤炭工业医学杂志, 2024, 27(3):307-312. Cited in this article [1]

[15]	Wong WK, Chan WK. Nonalcoholic fatty liver disease:a global perspective[J]. Clin Ther, 2021, 43(3):473-499.DOI:10.1016/j.clinthera.2021.01.007. Cited in this article [2]

[16]	Wang W, Ren J, Zhou W, et al. Lean non-alcoholic fatty liver disease(Lean-NAFLD)and the development of metabolic syndrome:a retrospective study[J]. Sci Rep, 2022, 12(1):10977.DOI:10.1038/s41598-022-14701-0. Cited in this article [1]

[17]	Ren TY, Fan JG. What are the clinical settings and outcomes of lean NAFLD[J]. Nat Rev Gastro Hepat, 2021, 18(5):289-290.DOI:10.1038/s41575-021-00433-5. Cited in this article [1]

[18]	滕笑丽. 新媒体语境下女性健康传播研究[D]. 武汉: 华中师范大学, 2019.DOI:10.27159/d.cnki.ghzsu.2019.000998. Cited in this article [1]

[19]	段涛, 谢幸, 孔北华. 妇产科学[M]. 9版. 北京: 人民卫生出版社,2018:137-138. Cited in this article [1]

[20]	靳雪征, 陈瑜, 许静, 等. 全国性控烟公益广告强化宣传效果调查分析[J]. 中国健康教育, 2022, 38(2):160-163,191.DOI:10.16168/j.cnki.issn.1002-9982.2022.02.013. Cited in this article [1]

[21]	中华人民共和国中央人民政府. 我国履行世卫组织《烟草控制框架公约》正式启动[EB/OL].( 2005-10-14)[2024-10-18]. https://www.gov.cn/jrzg/2005-10/14/content_77389.htm. https://www.gov.cn/jrzg/2005-10/14/content_77389.htm Cited in this article [1]

[22]	中华人民共和国中央人民政府. 中共中央国务院印发《“健康中国2030”规划纲要》[EB/OL].( 2016-10-25)[2024-10-18]. https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm. https://www.gov.cn/zhengce/2016-10/25/content_5124174.htm Cited in this article [1]